Elevance Health (ELV, Financial) has scheduled the release of its financial results for the first quarter of 2025 on April 22. The company reported that the trends in medical costs during the quarter aligned with their initial forecasts, particularly in their Medicare Advantage segment. Despite the elevated cost trends in Medicare Advantage, the company's performance matched its expectations and current pricing strategies.
Elevance Health maintains its projection for Medicare Advantage membership to range between 2.2 million and 2.25 million for the full year 2025. This forecast is consistent with the guidance shared during their Fourth Quarter 2024 Earnings Release in January 2025. Additionally, the company plans to reaffirm its adjusted net income guidance for 2025, expecting it to be within $34.15 to $34.85 per diluted share.
The company will offer further insights into its first quarter performance and its comprehensive outlook for the year when it releases its detailed report on April 22.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Elevance Health Inc (ELV, Financial) is $493.87 with a high estimate of $585.00 and a low estimate of $428.00. The average target implies an upside of 15.32% from the current price of $428.26. More detailed estimate data can be found on the Elevance Health Inc (ELV) Forecast page.
Based on the consensus recommendation from 24 brokerage firms, Elevance Health Inc's (ELV, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Elevance Health Inc (ELV, Financial) in one year is $622.65, suggesting a upside of 45.39% from the current price of $428.26. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Elevance Health Inc (ELV) Summary page.
